View in EDS

Antibody-Drug Conjugates Drug Product Formulation and Process Development, Scalability and Stability Considerations.

Saved in:
Bibliographic Details
Title: Antibody-Drug Conjugates Drug Product Formulation and Process Development, Scalability and Stability Considerations.
Authors: Sorret L; Drug Product Formulation Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland., Ninomiya M; Preclinical Development Bioconjugates, Lonza AG, Rottenstrasse 6, 3930, Visp, Switzerland., Hillebrandt N; Drug Product Process Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland., Schmitt D; Drug Product Formulation Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland., Chattopadhyay A; Drug Product Process Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland., McGarvey O; Drug Product Process Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland. orla.mcgarvey@lonza.com.
Source: AAPS PharmSciTech [AAPS PharmSciTech] 2026 Jun 04; Vol. 27 (5). Date of Electronic Publication: 2026 Jun 04.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932 (Electronic) Linking ISSN: 15309932 NLM ISO Abbreviation: AAPS PharmSciTech Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42243572
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antibody-Drug Conjugates Drug Product Formulation and Process Development, Scalability and Stability Considerations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sorret+L%22">Sorret L</searchLink>; Drug Product Formulation Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ninomiya+M%22">Ninomiya M</searchLink>; Preclinical Development Bioconjugates, Lonza AG, Rottenstrasse 6, 3930, Visp, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hillebrandt+N%22">Hillebrandt N</searchLink>; Drug Product Process Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schmitt+D%22">Schmitt D</searchLink>; Drug Product Formulation Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chattopadhyay+A%22">Chattopadhyay A</searchLink>; Drug Product Process Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22McGarvey+O%22">McGarvey O</searchLink>; Drug Product Process Development, Lonza AG, Hochbergerstrasse 60G, 4057, Basel, Switzerland. orla.mcgarvey@lonza.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100960111%22">AAPS PharmSciTech</searchLink> [AAPS PharmSciTech] 2026 Jun 04; Vol. 27 (5). <i>Date of Electronic Publication: </i>2026 Jun 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100960111 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1530-9932 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215309932%22">15309932 </searchLink><i>NLM ISO Abbreviation: </i>AAPS PharmSciTech <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42243572
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1208/s12249-026-03457-9
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Antibody-Drug Conjugates Drug Product Formulation and Process Development, Scalability and Stability Considerations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sorret L
      – PersonEntity:
          Name:
            NameFull: Ninomiya M
      – PersonEntity:
          Name:
            NameFull: Hillebrandt N
      – PersonEntity:
          Name:
            NameFull: Schmitt D
      – PersonEntity:
          Name:
            NameFull: Chattopadhyay A
      – PersonEntity:
          Name:
            NameFull: McGarvey O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 06
              Text: 2026 Jun 04
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1530-9932
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: AAPS PharmSciTech
              Type: main
ResultId 1